Fulgent Genetics, Inc. financial data

Symbol
FLGT on Nasdaq
Industry
Services-Medical Laboratories
Location
4399 Santa Anita Ave, El Monte, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Fulgent Diagnostics, Inc. (to 7/15/2016)
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 644 % -10.7%
Debt-to-equity 8.7 % +0.35%
Return On Equity -14.1 % -267%
Return On Assets -12.9 % -267%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.3M shares +1.24%
Common Stock, Shares, Outstanding 30.3M shares +1.15%
Entity Public Float 629M USD -35.7%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 30.1M shares +0.96%
Weighted Average Number of Shares Outstanding, Diluted 30.1M shares +0.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 291M USD -5.43%
Cost of Revenue 177M USD -15.3%
Research and Development Expense 46.9M USD +32.1%
Selling and Marketing Expense 38.2M USD -6.53%
General and Administrative Expense 92M USD -2.99%
Operating Income (Loss) -192M USD -137%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -164M USD -143%
Income Tax Expense (Benefit) 7.01M USD +31.7%
Net Income (Loss) Attributable to Parent -163M USD -236%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 65.1M USD +11.6%
Accounts Receivable, after Allowance for Credit Loss, Current 56.6M USD +62.5%
Other Assets, Current 30.8M USD -12.1%
Assets, Current 399M USD -24.5%
Property, Plant and Equipment, Net 93.4M USD +6.64%
Operating Lease, Right-of-Use Asset 9.19M USD -34.7%
Intangible Assets, Net (Excluding Goodwill) 139M USD -5.12%
Goodwill 22.1M USD -84.5%
Other Assets, Noncurrent 32.1M USD -34.5%
Assets 1.23B USD -9.03%
Accounts Payable, Current 19.9M USD -3.56%
Accrued Liabilities, Current 26.4M USD +18.9%
Contract with Customer, Liability, Current 2.74M USD +5.5%
Liabilities, Current 75.8M USD +16.9%
Deferred Income Tax Liabilities, Net 6.95M USD
Operating Lease, Liability, Noncurrent 7.16M USD -14.6%
Other Liabilities, Noncurrent 14.4M USD -13.3%
Liabilities 103M USD +13.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -877K USD +95.8%
Retained Earnings (Accumulated Deficit) 611M USD -21.1%
Stockholders' Equity Attributable to Parent 1.13B USD -10.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.13B USD -10.6%
Liabilities and Equity 1.23B USD -9.03%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.27M USD
Net Cash Provided by (Used in) Financing Activities -2.81M USD -155%
Net Cash Provided by (Used in) Investing Activities -47.2M USD -984%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 33M shares +4.12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -42.8M USD -221%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 65.1M USD +11.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 439K USD
Deferred Tax Assets, Valuation Allowance 15.9M USD +461%
Deferred Tax Assets, Gross 45.7M USD -19.2%
Operating Lease, Liability 9.44M USD -34.1%
Depreciation 17.3M USD -27.9%
Payments to Acquire Property, Plant, and Equipment 4.06M USD +99.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -144M USD -205%
Lessee, Operating Lease, Liability, to be Paid 10.9M USD -30.5%
Property, Plant and Equipment, Gross 139M USD +1.15%
Operating Lease, Liability, Current 2.29M USD -61.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.97M USD -18.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.55M USD -41.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +24.9%
Deferred Income Tax Expense (Benefit) -557K USD +89.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.47M USD +5.84%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.89M USD +5.6%
Deferred Tax Assets, Operating Loss Carryforwards 17.5M USD +7.04%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 6.3M USD -36%
Lessee, Operating Lease, Liability, to be Paid, Year Four 514K USD -69.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 7.9M USD -0.64%
Depreciation, Depletion and Amortization 6.15M USD -2.52%
Deferred Tax Assets, Net of Valuation Allowance 29.8M USD -44.5%
Share-based Payment Arrangement, Expense 45.5M USD +14.9%
Interest Expense 498K USD +134%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%